// App-Quantinova.ai

: Combination Chemotherapy Plus Dasatinib Leads to Comparable Rates of Overall Survival and Relapse-Free Survival As Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Positive Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Jeremy Chang

Principal Investigators

  • Golnaz Vahdani

  • George Yaghmour

  • Kum-Ja Lee

  • Ashley Weissman

  • Mojtaba Akhtari

Medical Centers

  • Los Angeles County + University of Southern California, Wilmington, CA

  • Los Angeles County Hospital/ University of Southern California, Los Angeles, CA

  • Jane Anne Nohl Division of Hematology Center for the Study of Blood Diseases, Los Angeles, CA

  • University of Southern California Keck School of Medicine, Los Angeles, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Pegaspargase

  • Oncaspar

  • dasatinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved